Comparison of the perp of the surgical location with betadine 10% versus chlorhexidine gluconate 4% on the incidence rate and the severity of wound infection after upper limb orthopedic elective surgery

Comparison of the perp of the surgical location with betadine 10% versus chlorhexidine gluconate 4% on the incidence rate and the severity of wound infection after upper limb orthopedic elective surgery: a double-blind randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N315

Enrollment

140

Registered

2019-10-30

Start date

2019-11-22

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical wound infection. Infection following a procedure

Interventions

Intervention 1: Intervention group:Perp of the surgical location with chlorhexidine gluconate 4% for 3 minutes. Intervention 2: Control group:Perp of the surgical location with betadine 10% for 3 minu

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age:18 to 60 years old Candidate for upper limb orthopedic elective surgery Body mass index less than 30 Normal white blood cell count

Exclusion criteria

Exclusion criteria: Open fracture History of upper limb surgery Presence of scar on the upper limb Affected with infectious diseases Diabetes or vascular disorders Immunodeficiency Taking immunosuppressive drugs Using alcohol or smoking cigarette

Design outcomes

Primary

Measure	Time frame
The incidence rate of wound infection. Timepoint: One week after surgery. Method of measurement: Thorough physical examination.;The severity of wound infection. Timepoint: One week after surgery. Method of measurement: By Asepsis index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Gholamveisi

Sanandaj University of Medical Sciences

behzad.gholamveisi@gmail.com+98 87 3366 4600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026